Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi Y Kim

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|June 7, 2025
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trialD Ware Branch, Mimi Y Kim, Marta M Guerra, et al.
International Journal of Cancer|March 1, 2018
Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal womenGeoffrey C Kabat, Mimi Y Kim, Marcia Stefanick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2David S Geller, Michael Y Singh, Wendong Zhang, et al.
Arthritis Research & Therapy|March 20, 2020
Low frequency of flares during pregnancy and post-partum in stable lupus patientsJulia Davis-Porada, Mimi Y Kim, Marta M Guerra, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 30, 2006
Health disparities between island and mainland Puerto RicansGloria Y F Ho, Hong Qian, Mimi Y Kim, et al.
Lupus Science & Medicine|February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsCecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 14, 2018
Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal womenGeoffrey C Kabat, Mimi Y Kim, Dorothy S Lane, et al.
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesCecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodiesMimi Y Kim, Marta M Guerra, Elianna Kaplowitz, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|June 7, 2025
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trialD Ware Branch, Mimi Y Kim, Marta M Guerra, et al.
International Journal of Cancer|March 1, 2018
Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal womenGeoffrey C Kabat, Mimi Y Kim, Marcia Stefanick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2David S Geller, Michael Y Singh, Wendong Zhang, et al.
Arthritis Research & Therapy|March 20, 2020
Low frequency of flares during pregnancy and post-partum in stable lupus patientsJulia Davis-Porada, Mimi Y Kim, Marta M Guerra, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 30, 2006
Health disparities between island and mainland Puerto RicansGloria Y F Ho, Hong Qian, Mimi Y Kim, et al.
Lupus Science & Medicine|February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsCecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 14, 2018
Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal womenGeoffrey C Kabat, Mimi Y Kim, Dorothy S Lane, et al.
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesCecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodiesMimi Y Kim, Marta M Guerra, Elianna Kaplowitz, et al.
Pageof 9